Abstract:The developmental process of central nervous system (CNS) myelin sheath formation is characterized by well-coordinated cellular activities ultimately ensuring rapid and synchronized neural communication. During this process, myelinating CNS cells, namely oligodendrocytes (OLGs), undergo distinct steps of differentiation, whereby the progression of earlier maturation stages of OLGs represents a critical step toward the timely establishment of myelinated axonal circuits. Given the complexity of functional integration, it is not surprising that OLG maturation is controlled by a yet fully to be defined set of both negative and positive modulators. In this context, we provide here first evidence for a role of lysophosphatidic acid (LPA) signaling via the G protein-coupled receptor LPA6 as a negative modulatory regulator of myelination-associated gene expression in OLGs. More specifically, the cell surface accessibility of LPA6 was found to be restricted to the earlier maturation stages of differentiating OLGs, and OLG maturation was found to occur precociously in Lpar6 knockout mice. To further substantiate these findings, a novel small molecule ligand with selectivity for preferentially LPA6 and LPA6 agonist characteristics was functionally characterized in vitro in primary cultures of rat OLGs and in vivo in the developing zebrafish. Utilizing this approach, a negative modulatory role of LPA6 signaling in OLG maturation could be corroborated. During development, such a functional role of LPA6 signaling likely serves to ensure timely coordination of circuit formation and myelination. Under pathological conditions as seen in the major human demyelinating disease multiple sclerosis (MS), however, persistent LPA6 expression and signaling in OLGs can be seen as an inhibitor of myelin repair. Thus, it is of interest that LPA6 protein levels appear elevated in MS brain samples, thereby suggesting that LPA6 signaling may represent a potential new druggable pathway suitable to promote myelin repair in MS.

Wnt-LRP6 signaling pathway regulates the expression of REST and its neuroprotective function

REST alleviates neurotoxic prion peptide-induced synaptic abnormalities, neurofibrillary degeneration and neuronal death partially via LRP6-mediated Wnt-β-catenin signaling.

Downregulation of the Repressor Element 1-Silencing Transcription Factor (REST) is Associated with Akt-mTOR and Wnt-β-Catenin Signaling in Prion Diseases Models

REST protects primary cortical neurons from PrP106-126-induced synaptic damage and neurofibrillary degeneration

REST Alleviates Neurotoxic Prion Peptide PrP106-126-induced Primary Cortical Neuronal Death

Lithium Alleviates Neurotoxic Prion Peptide-Induced Synaptic Damage and Neuronal Death Partially by the Upregulation of Nuclear Target REST and the Restoration of Wnt Signaling

Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease

LRP5/6 Directly Bind to Frizzled and Prevent Frizzled-regulated Tumour Metastasis.

Lysophosphatidic Acid Signaling Via LPA6: A Negative Modulator of Developmental Oligodendrocyte Maturation

Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice

DLP1-dependent Mitochondrial Fragmentation and Redistribution Mediate Prion-Associated Mitochondrial Dysfunction and Neuronal Death

Low‐density Lipoprotein Receptor‐related Protein 6 Regulates Alternative Pre‐mrna Splicing

Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice

Prion protein is essential for the RE1 silencing transcription factor (REST)-dependent developmental switch in synaptic NMDA receptors

Death Receptor 6 and Caspase-6 Regulate Prion Peptide-Induced Axonal Degeneration in Rat Spinal Neurons

Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function

Altered Expression of Neurotrophin Receptor P75 NTR in PrP106-126-induced Neurotoxicity of N2a Cells

NLRP6 deficiency inhibits neuroinflammation and ameliorates brain injury in ischemic stroke by blocking NLRs inflammasomes activation through proteasomal degradation of pro-caspase-1

Suppression of LINC00707 Alleviates Lipopolysaccharide-Induced Inflammation and Apoptosis in PC-12 Cells by Regulated Mir-30A-5p/neurod 1.

LRP4-related signalling pathways and their regulatory role in neurological diseases

HDAC6 alleviates prion peptide-mediated neuronal death via modulating PI3K-Akt-mTOR pathway.